BRPI0821660A2
(en )
2015-06-16
Combinations of therapeutic agents for cancer treatment
BRPI0821779A2
(en )
2019-09-24
therapeutic treatment of cancer
CY2017010I2
(en )
2017-11-14
THERAPEUTIC AGENTS FOR LOWERING PARATHORMONE LEVELS
CY2014006I1
(en )
2019-11-27
METHODS OF THERAPEUTIC TREATMENT USING GLYCOPEGYLATE G-CSF
BRPI0916931A2
(en )
2015-11-24
therapeutic agents
HK1211889A1
(en )
2016-06-03
Therapeutic use of diaminophenothiazines
BRPI0922823A2
(en )
2015-08-18
Combinations and modes of administration of therapeutic agents and combination therapy
IL216913A0
(en )
2012-02-29
Targeted nano-photomedicines for photodynamic therapy of cancer
ZA200905159B
(en )
2010-05-26
Combination of LBH589 with other therapeutic agents for treating cancer
DK2121139T3
(en )
2013-01-14
FORMULATIONS FOR CANCER TREATMENT
BRPI1006438A2
(en )
2016-09-27
adjuvant cancer therapy
DK2144905T3
(en )
2013-03-11
Therapeutic agents
EP2254411A4
(en )
2012-06-13
Complement inhibitors as therapeutic agents for treatment of cancer
IL200525A0
(en )
2010-04-29
Methods of treating cancer by administering human il-18 combinations
SMT201600041B
(en )
2016-02-25
THERAPEUTIC AGENTS 713
EP2029156A4
(en )
2010-07-21
Combination therapy for treatment of cancer
IL275636A
(en )
2020-08-31
Therapeutic combination for the treatment of cancer
BRPI0924107A2
(en )
2019-09-24
hsp90 inhibitors for therapeutic treatment
BRPI1013903A2
(en )
2016-07-19
therapeutic treatments using centaquin
EP2486929A4
(en )
2013-04-03
Therapeutic agent for tumor
BRPI0909764A2
(en )
2015-10-06
therapeutic compounds
BRPI0906879A2
(en )
2015-07-07
Therapeutic compounds
BRPI0913939A2
(en )
2016-04-26
unit dose of apadenoson
TH0801000600A
(en )
2015-02-20
Combination of Therapeutic Agents for Cancer Therapy
BRPI0911543A2
(en )
2015-10-13
substituted arylcyclopentenes as therapeutic agents